Jacobio Pharmaceuticals Group Co., Ltd. (01167) submitted a Monthly Return for the period ended 31 January 2026. The authorized share capital remained at 1,000,000,000 ordinary shares with a par value of USD 0.0001 each, totaling USD 100,000 and showing no change within the month.

The number of issued shares (excluding treasury shares) at the end of January was 786,672,780, while treasury shares increased to 5,082,300. The total number of issued shares stayed at 791,755,080. These changes resulted from two share repurchases: 150,000 shares on 2 January 2026 at HKD 6.44 each and 240,000 shares on 6 January 2026 at HKD 6.19 each.

According to the filing, the company maintained compliance with the applicable public float requirement of 25%. The announcement was filed by Director Xiaojie Wang on 5 February 2026.